Pluribus Labs, LLC Pfizer Inc Transaction History

Pluribus Labs, LLC

  • $54.8 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$46.53 - $55.17 $229,625 - $272,263
-4,935 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$45.75 - $56.69 $236,939 - $293,597
-5,179 Reduced 51.21%
4,935 $255,000
Q4 2021

Feb 14, 2022
BUY
$41.32 - $61.25 $417,910 - $619,482
10,114 New
10,114 $597,000

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pluribus Labs, LLC Portfolio

Follow Pluribus Labs, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pluribus Labs, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pluribus Labs, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email